Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT02815891 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

NCT NCT02815891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02815891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
May 31, 2026
Enrollment
7,330 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver, nonalcoholic steatohepatitis